Pseudoephedrine; Triprolidine

Drug Usage Statistics, United States, 2013 - 2021

Pseudoephedrine; Triprolidine Summary for 2021

Top drug rank #349 (no previous rank)
Estimated number of prescriptions in the United States (2021) 102,352
Estimated number of patients in the United States (2021) 25,588
Average total drug cost (USD)  
Per prescription $3.45
Per day of therapy $0.21/day
Average out-of-pocket cost (USD)  
Per prescription $3.45
Per day of therapy $0.21/day

Total Prescriptions and Patients Per Year (2013 - 2021)

Rank of Top Drugs Over Time

"Rank" refers to the frequency that a given medication is prescribed within a calendar year compared to all other medications. A rank of "4" would indicate that the medication was the fourth most commonly prescribed medication.

Year Rank Change
2013 460  279
2014 428  32
2015 488  60
Year Rank Change
2016 477  11
2019 469 -
2021 349 -

Drug Cost Over Time (2013 - 2021)

  • Cost Per Prescription Fill: Average cost per filled prescription regardless of how many days of therapy the prescription is filled for (e.g. 10 days, 30 days, 90 days, etc.)
  • Cost per Day of Therapy: The average cost per prescription fill divided by the days of therapy. For example, a 10-day antibiotic course costing $30 would be $3 per day. Similarly, a 30-day supply of an oral antihypetensive costing $30 would be $1 per day.

  • Total cost: The average total cost of the medication including the out-of-pocket cost (see below) plus the amount paid by other parties (Medicare, Medicaid, private insurance, Veterans Administration, TRICARE, other state/federal sources, Worker's compensation, and other miscellaneous sources)
  • Out-of-pocket cost: The average payment made by the patient which may include deductibles, coinsurance, copayments, or the cash price paid without insurance coverage.

Cost Per Prescription Fill (USD)

Cost Per Day of Therapy (USD/day)

Distribution of Dispensed Dosage Forms (2021)

No data available

Distribution of Days Supplied (2021)

"Days supply" is defined as the number of days that a prescription should last. For example, a prescription of 60 tablets that is taken twice daily has a day supply of 30 days.

Related Drugs

Drug Name Total Prescriptions (2021)
Brimonidine 3,470,856
Epinephrine 1,896,954
Fexofenadine; Pseudoephedrine 829,016
Brompheniramine; Dextromethorphan; Pseudoephedrine 584,348
Loratadine; Pseudoephedrine 362,280
Pseudoephedrine 295,652
Pseudoephedrine; Triprolidine (this drug) 102,352
Cetirizine; Pseudoephedrine 66,267
Guaifenesin; Pseudoephedrine 5,925
Pseudoephedrine; Codeine; Guaifenesin 2,532

Drug Synonyms

Drug synonyms are used during the sanitation and standardization process of "cleaning" the original data source (MEPS). Occassionally, brand names may be listed below that are no longer on the market or are very infrequently used.

Brand Name Synonyms
  • Actahist
  • Actifed
  • Allerfed
  • Corphed
  • Histafed
  • Myfed
  • Pseudoephedrine Hydrochloride And Triprolidine Hydrochloride
  • Trilitron
  • Triphed
  • Triprolidine And Pseudoephedrine
  • Triprolidine And Pseudoephedrine Hydrochlorides
  • Triprolidine Hydrochloride And Pseudoephedrine Hydrochloride
Generic Drug Synonyms and Salts
  • Pseudoephedrine Hydrochloride; Triprolidine Hydrochloride
  • Pseudoephedrine; Triprolidine

FDA Approval Information

Established Pharmacologic Class (EPC): alpha-Adrenergic Agonist
Initial FDA approval date: 3/4/1983
First FDA applicant: Discn
First dosage form: Syrup (oral)

Prescription data source: Medical Expenditure Panel Survey (MEPS) 2013-2021. Agency for Healthcare Research and Quality (AHRQ), Rockville, MD. ClinCalc DrugStats Database version 2024.01. Read more about the ClinCalc DrugStats database.

All ClinCalc DrugStats figures and graphs on this page are licensed under Creative Commons Attribution-ShareAlike 4.0 International (CC BY-SA 4.0).


Related Links

Follow Us!

New and Popular


Open Menu

Cite This Page

Show AMA citation

Which of these drugs causes acute kidney injury? The Top 250 Drugs by ClinCalc Academy
©2024 - ClinCalc LLC. All rights reserved.
Disclaimer - Privacy Policy - Contact Us
Updated Sep 12, 2021
Back to Top